GALWAY, IRELAND--August 31, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Mylan Ireland Limited (NASDAQ: MYL) has agreed to buy Aspen Pharmacare Holdings's European thrombosis business for 642 million euro ($763 million).

Within this article: Details purchase, price paid, products acquired, strategic directions of both companies, related deals

Login to Read More